News & Insights

Gide has advised the banking syndicate composed of Leerink Partners, Stifel and Baird on the €60 million financing by Sensorion, including a €20 milli...

Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associ...

Gide advises the banks’ syndicate, including Leerink Partners, Piper Sandler & Co. and Guggenheim Securities, as joint bookrunning managers, LifeS...

Gide advised Agence des Participations de l’Etat on Eutelsat’s capital strengthening project. Eutelsat plans to raise €1.35 billion in capital through...

Gide has advised Inventiva, a biopharmaceutical company listed on Euronext Paris and Nasdaq, on the issuance of the second tranche of the structured f...

Gide advised DBV Technologies, a dual listed company on Euronext Paris and the Nasdaq, on a financing of up to $306.9 million (€284.5 million) through...

Gide advised the biopharmaceutical company Inventiva, a company listed on Euronext Paris and Nasdaq, in an immediate financing of €94.1 million and up...

Gide advised Younited, a regulated player in the European consumer credit market, on its merger with Iris Financial, a company listed on Euronext Amst...

Gide advised the banks syndicate, including Crédit Agricole CIB and Société Générale, on the €131 million capital increase with preferential subscript...

Gide has advised AIPCF VI LG Funding, LP, an affiliate of American Industrial Partners (“AIP“) in connection with the sale of 1,500,000 sh...